Can artificial intelligence function as a partner in scientific discovery, capable of generating novel, testable hypotheses ...

An MIT team used artificial intelligence to design novel antibiotics, two of which showed promise against MRSA and gonorrhea.

In this webinar, Jae Chang Lim and Hyun Joon Chang will discuss how a cutting-edge artificial intelligence platform is transforming early-stage drug discovery.

The healthtech industry is on track to triple from $352 in 2025 to over $1.1T by 2032, driven by critical needs in provider capacity, aging populations, and chronic disease management.

The field of oncology continues to confront the formidable challenge of addressing cancer, a leading cause of mortality ...

Following three years of internal development, Expedition Medicines is taking flight. The company is supported by a $50 ...

Duke researchers have developed a new AI-powered approach to nanoparticle drug delivery design, which performed well in lab tests with cancer drugs Drugs that fight diseases work best when they reach ...

The integration of single-cell RNA sequencing (scRNA-seq) with AI has become a cornerstone for deciphering tumor heterogeneity. For instance, in pancreatic ductal adenocarcinoma (PDAC), spatial ...

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant ...

(Reuters) -U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical, deepening their use of artificial intelligence ...

Computational drug discovery and design integrates advanced computer‐aided methodologies with chemical and biological insights to accelerate the identification and optimisation of therapeutic agents.